239
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model

, , , , , , & show all
Pages 595-605 | Received 11 Mar 2003, Accepted 11 Mar 2004, Published online: 09 Jul 2009

References

  • Tanaka R, Kim CH, Yamada N, Saito Y. Radiofrequency hyperthermia for malignant brain tumours. Neurosurgery 1987; 21: 478–83.
  • Takahashi H, Tanaka R, Hondo H, Nakajima T, Watanabe M, Sekihara Y, Kakinuma K. Clinical experiences of RF hyperthermia for malignant brain tumour. Neurosurgeons 1993; 12: 245–55.
  • Takahashi H, Tanaka R, Hondo H, Sekihara Y, Nakajima T. Preclinical experiments of RF interstitial hyperthermia with phantom and animals. Proc 7th Ann Meet Jap Soc Hypertherrnic Oncol. Tokyo, Japan, 1990; 87–8.
  • Takhashi H, Tanaka R, Uzuka T, Kon T, Aoki H, Endo S, Kano M, Igor G. Successful treatment of malignant glioma in the elderly by radiofrequency interstitial hyperthermia: a report of two cases. Jpn J Hypertherrnic Oncol 2002; 18: 157–63.
  • Von Holst H, Knochenhauer E, Blomgren H, Collins VP, Ehn L, Lindquist M, Noren G, Peterson C. Uptake of adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas. Acta Neurochir 1990; 104: 13–16.
  • Yuki K, Uozumi T, Komada Y, Kurisu K, Mikami T. In vitro chemosensitivity test of human brain tumours using a three-dimensional organ culture with a collagen gel matrix. J Neurooncol 1994; 21: 225–32.
  • Darling JL, Thomas DG. Response of short-term cultures derived from human malignant glioma to aziridinylbenzoquinone, etposide and doxorubicin: an in vitro phase II trial. Anti-cancer Drugs 2001; 12: 753–60.
  • Watanabe M, Tanaka R, Hondo H, Kuroki M. Effect of antineoplastic agents and hyperthermia on cytotoxicity toward chronically hypoxic glioma cells. Int J Hypertherrnia 1992; 8: 131–8.
  • Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978; 202: 1290–3.
  • Weinstein JN, Magin RL, Yatvin MB, Zaharko DS. Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumours. Science 1979; 204: 188–91.
  • Weinstein JN, Magin RL, Cysyk RL, Zaharko DS. Treatment of solid L1210 murine tumours with local hyperthermia and temperature-sensitive liposomes containing methotrexate. Cancer Res 1980; 40: 1388–95.
  • Iga K, Hamaguchi N, Igari Y, Gotoh K, Ootsu K, Toguchi H, Shimamoto T. Enhanced antitumour activity in mice after administration of thermosensitive liposome encapsulat-ing cisplatin with hyperthermia. J Pharrnacol Exp Ther 1991; 257: 1203–7.
  • Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, Papahadjopoulos D. Liposomes and hyperthermia in mice: increased tumour uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994; 54: 2186–91.
  • Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999; 15: 345–70.
  • Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn J Cancer Res 1998; 89: 463–9.
  • Kakinuma K, Tanaka R, Takahashi Y, Sekihara M, Watanabe M, Kuroki M. Drug delivery to the brain using thermosensitive liposome and local hyperthermia. Int J Hyperthermia 1996; 12: 157–65.
  • Kakinuma K, Tanaka R, Takahashi Y, Watanabe M, Nakagawa T, Kukoki M. Targeting chemotherapy for malignant brain tumour using thermosensitive liposome and localized hyperthermia. J Neurosurg 1996; 84: 180–4.
  • Merlin JL. Encapsulation of doxorubicin in thermosensitive small unilamellar vesicle liposomes. Eur J Cancer 1991; 27: 1026–30.
  • Iga K. Optimum formation of thermosensitive liposome for targeted tumour drug delivery. J Takeda Res Lab 1992; 51: 45–72.
  • Gaber MH, Wu NZ, Hong K, Huang SK, Dewhirst MW, Papahadjopoulos D. Thermosensitive liposomes: extravasation and release of contents in tumour microvascu-lar networks. Int J Radiat Oncol Biol Phys 1996; 36: 1177–87.
  • Song C. Effects of local hyperthermia on blood flow and microenvironment. Cancer Res 1984; 44: 4721S–30S.
  • Morita K, Tanaka R, Kakinuma K, Takahashi H, Motoyama H. Combination therapy of rat brain tumours using localized interstitial hyperthermia and intra-arterial chemo-therapy. Int J Hyperthermia 2003; 19: 204–12.
  • Koukourakis MI, Koukouraki S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S, Karkavitsas N. High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours. Br J Cancer 2000; 83: 1281–6.
  • Siegal T, Horowitz A, Gabizon A. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumour model: biodistribution and therapeutic efficacy. J Neurosurg 1995; 83: 1029–37.
  • Davis HL, Davis TE. Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations. Cancer Treat Rep 1979; 63: 809–15.
  • Fabel K, Dietrich J, Hau P, Wismeth C, Winner B, Prxywara S, Steinbrecher A, Ullrich W, Bogdahn U. Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer 2001; 92: 1936–42.
  • Voulgaris S, Partheni M, Karamouzis M, Dimopoulos P, Papadakis N, Kalofonos HP. Intratumoural doxorubicin in patients with malignant brain gliomas. Am J Oncol 2002; 25: 60–4.
  • Coley HM, Amos WB, Twentyman PR, Workman P. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localization of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer 1993; 67: 1316–23.
  • Meschini S, Molinari A, Calcabrini G, Citro G, Arancia G. Intracellular localization of the antitumour drug adriamycin in living cultured cells: a confocal microscopy study. J Microscopy 1994; 176: 204–10.
  • Belhoussine R, Morjani H, Millot JM, Sharonov S, Manfait M. Confocal scanning microscopectrofluorometry reveals specific anthracycline accumulation in cytoplasmic organelles of multidrug-resistant cancer cells. J Histochern Cytochern 1998; 46: 1369–76.
  • Kabuto M, Kubota T, Kobayashi H, Nakagawa T, Kitai R. The antitumour effect of MX2, a new morpholino anthracycline, against malignant glioma cell lines and its subcellular distribution. Neurosurgery 1995; 37: 471–7.
  • Di Marco A, Adriamycin: mode and mechanism of action. Cancer Chernother Rep 1975; 6: 91–106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.